CMR Surgical's new CEO stopped the company's US market launch in his first week on the job. Not because of a regulatory problem, not because of a product failure, but because he assessed that the product ready for launch was not the right product to launch with. That decision is a case study in the kind of execution discipline that separates founders who build lasting medical device companies from those who spend years recovering from a bad market entry.
If You Are Building a Company in This Environment
The surgical robotics market in 2026 is not forgiving of early missteps. Hospitals make capital commitments that last a decade. Clinical champions stake professional reputations on the platforms they advocate for. OR staff train on systems and build institutional knowledge around them. When you enter this market, you are not making a product sale. You are asking someone to reorganize their workflow, retrain their team, and defend that decision to their procurement committee.
If you are building a company in this environment, whether you are the platform or the enabling device or the software layer that runs on top, the quality of your first impression is not a marketing question. It is a strategic one. CMR's CEO understood this. His decision to wait was not timidity. It was precision.
This is exactly the territory that Founders Who Finish covers. Not how to launch fast. How to launch right, and what that requires in terms of preparation, discipline, and willingness to hold the line when the organization has momentum in the wrong direction.
Why Most Founders Get Market Entry Wrong
The most common mistake founders make in a regulated market is treating launch readiness as a product question rather than a market execution question. They ask: is the product ready to ship? When the right question is: are we ready to win with this product in this market at this moment?
Those are different questions with different answers. A product can be technically functional, FDA cleared, and commercially available, and still be the wrong product to launch with if the value story is not clear, the clinical evidence is not sufficient, the support infrastructure is not ready, or the target accounts are not the right ones for where you are in the product's development.
CMR's original Versius system worked. It had been used on more than 45,000 patients across 30-plus countries. The problem was not that it was broken. The problem was that Versius Plus was materially better, and entering the US market with the second-generation product changed the story CMR could tell. In a market where first impressions are durable, that difference matters.
What Execution Discipline Actually Looks Like
Execution discipline is not a personality trait. It is a set of organizational practices that make it possible to hold a high standard even when there is pressure to move faster than the situation warrants. In Founders Who Finish, the execution framework is structured around five principles that apply as directly to a market launch as they do to a product development sprint.
Principle 1
Define the win condition before you start
Founders who finish know what done looks like before they begin. For a market entry, that means defining the specific outcome you are optimizing for: not just "get to market" but "establish three reference accounts in tier-one academic medical centers by end of year." The specificity of the target shapes every decision that follows.
Principle 2
Separate momentum from progress
Organizations build momentum toward a launch date. Teams get excited. Investors expect milestones. Sales teams start making promises. That momentum is not the same as being ready. Founders who finish maintain the ability to distinguish between org-wide excitement about shipping and the evidence-based assessment of whether shipping is the right move.
Principle 3
Know what you cannot afford to get wrong
Not every decision in a company has the same consequence for failure. CMR's CEO identified US market entry as a decision where a single mistake would be extremely costly. Once you know what you cannot afford to get wrong, you can calibrate the level of rigor and preparation that decision deserves. Most companies apply the same process to every decision, which is the wrong approach.
Principle 4
Build the infrastructure before you need it
The gap between a cleared product and a successful market launch is filled with organizational infrastructure: clinical support, service contracts, training programs, reimbursement pathways, account management relationships. Founders who finish build this infrastructure before they are in front of customers, not after. The companies that stumble at launch almost always stumble because this work was deferred.
Principle 5
Make the hard call when the evidence requires it
Colella made a hard call under pressure. He stopped a launch that the entire organization had been building toward. That is an execution skill, and it can be developed. Founders who finish build the organizational culture and decision-making processes that make it possible to stop, reassess, and change direction when the evidence requires it, without catastrophizing about the delay or demoralizing the team.
The Long-Term Value of Getting the Launch Right
Companies that get market entry right in regulated sectors accumulate compounding advantages. The first accounts become reference sites. Reference sites generate the clinical evidence that funds the next set of conversations. Those conversations produce the hospital champions who carry the message into their peer networks. The cost of a bad first impression is not just the lost account. It is the reference you do not have, the evidence you cannot point to, and the champion who went silent instead of going active.
This is why Founders Who Finish focuses on the mechanics of execution rather than the theory of strategy. Understanding what to do is rarely the bottleneck for founders in complex markets. Knowing how to build the organizational infrastructure to do it consistently, and the discipline to hold the line when pressure to move fast exceeds the readiness to do so, is where most companies find their limits.
Founders Who Finish
The book for founders who want to build something that lasts
Available now at davesaunders.net/book. Practical execution frameworks for founders building complex products in regulated markets.
Get the book →